Hippocampal subfields volumes and affective symptoms of patients with mesial temporal lobe epilepsy
- PMID: 40690889
- DOI: 10.1016/j.yebeh.2025.110597
Hippocampal subfields volumes and affective symptoms of patients with mesial temporal lobe epilepsy
Abstract
Background: Hippocampal sclerosis (HS) is the most frequent neuropathological finding in mesial temporal lobe epilepsy (MTLE-HS), leading to hippocampal atrophy due to neuronal loss and gliosis. Anxiety and depression are highly prevalent in drug-resistant MTLE-HS patients, but their neuroanatomical correlates remain unclear. This study investigates the independent association between affective symptoms and hippocampal subfield volumes in unilateral MTLE-HS.
Methods: We analyzed 46 consecutive patients with unilateral drug-resistant MTLE-HS using MRI-based volumetry of hippocampal subfields on both the sclerotic (HS) and contralateral (non-HS) sides. The Hospital Anxiety and Depression Scale (HADS) was used to assess affective symptoms. Subfields were segmented into anterior and posterior regions, and multiple linear regression models controlled for demographic and clinical variables.
Results: No significant associations were found between HS laterality and affective symptoms. Depressive symptoms (HADS-D) were not linked to hippocampal subfield volumes on either side. In contrast, anxiety symptoms (HADS-A) correlated with multiple non-HS subfields in univariate analyses, but only the posterior dentate gyrus (DG) remained significantly and negatively associated with HADS-A scores (β = -67.94, r2 = 0.16, p < 0.01) in multivariate analysis.
Conclusions: In patients with unilateral MTLE-HS the levels of depressive symptoms were not independently associated with hippocampal subfield volumes. The posterior DG volume of the non-HS side presented a r2 of 0.16 in our final model. These findings highlight the potential role of hippocampal morphology in anxiety pathophysiology among MTLE-HS patients and contribute to understanding neuroimaging markers of affective symptoms in epilepsy.
Keywords: Anxiety; Depression; Hippocampal Sclerosis; Hippocampal Subfields; MRI; Mesial Temporal Lobe Epilepsy.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Glucose Metabolism of Hippocampal Subfields in Medial Temporal Lobe Epilepsy.Clin Nucl Med. 2024 Apr 1;49(4):294-300. doi: 10.1097/RLU.0000000000005105. Epub 2024 Feb 22. Clin Nucl Med. 2024. PMID: 38382495
-
Quantification of subfield pathology in hippocampal sclerosis: a systematic review and meta-analysis.Epilepsy Res. 2014 Oct;108(8):1279-85. doi: 10.1016/j.eplepsyres.2014.07.003. Epub 2014 Jul 23. Epilepsy Res. 2014. PMID: 25107686
-
Brain Hypertrophy in Patients With Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis and Its Clinical Correlates.Neurology. 2025 Jan 28;104(2):e210182. doi: 10.1212/WNL.0000000000210182. Epub 2024 Dec 23. Neurology. 2025. PMID: 39715478 Free PMC article.
-
Pattern of abnormalities on gray matter in patients with medial temporal lobe epilepsy and hippocampal sclerosis: An updated meta-analysis.Clin Neurol Neurosurg. 2024 Oct;245:108473. doi: 10.1016/j.clineuro.2024.108473. Epub 2024 Aug 3. Clin Neurol Neurosurg. 2024. PMID: 39154538 Review.
-
Surgery for epilepsy.Cochrane Database Syst Rev. 2015 Jul 1;(7):CD010541. doi: 10.1002/14651858.CD010541.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2019 Jun 25;6:CD010541. doi: 10.1002/14651858.CD010541.pub3. PMID: 26130264 Updated.
LinkOut - more resources
Full Text Sources